Clinical Trial Update: DLBS1033 for Acute Ischemic Stroke Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for DLBS1033 in acute ischemic stroke (Phase 2/Phase 3) shows termination of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lacunar Anterior Circulation Infarct
• Partial Anterior Circulation Infarct
• Stroke

Drugs mentioned

• DLBS1033 (DLBS1033)

Snippet

Sponsor: Dexa Medica Group | Conditions: Acute Ischemic Stroke, Partial Anterior Circulation Infarct | Phase 2, Phase 3 | Status: TERMINATED